Archives: Speakers
Laura Taraboanta
Laura Taraboanta, MS is a clinical strategy and development professional with a demonstrated history in health care and clinical trials. She is currently the of Head Clinical Innovation at Click Therapeutics, with a focus on improving speed, efficiency, and cost of prescription digital therapeutics discovery, development and implementation. Prior to Click, Laura was leading clinical operations at Woebot Health, a mental health company focused on delivering evidence-based treatment through an AI chatbot. Laura has been part of two successful FDA Breakthrough Designations for software as medical devices and has overseen numerous research projects in CNS and oncology, tapping into the potential of virtual trials to empower patients. Laura is keen on tackling health disparities by accelerating digital therapeutic development so that clinically-proven, safe and effective solutions can be universally available to patients and their providers.
Janet Peterson
Jenn Curry
Jenn Curry is Head of Patient Engagement Capability at Biogen. In this role, Jenn is accountable for driving the capabilities optimizes the execution of patient-focused drug development and maximizes the degree of impact on enrollment and the participant experience in Biogen’s clinical studies. Jenn entered the field of clinical research as a Research Assistant at Massachusetts General Hospital in 2003 and shifted her focus to industry, specifically patient recruitment, in 2006. Prior to joining Biogen in 2019, she spent 9 years at AES/Acurian Inc., advancing from Project Manager to Director of Operational and Strategic Solutions while honing her expertise in patient recruitment.
Milica Kakarla
Patrick Ezeh
Hasim Khorakiwala
Marilyn Fontaine
Marilyn is currently Director of Clinical Operations at Nuvation Bio. She has dedicated the past 12 years to clinical development and operations, with a sole focus in oncology drugs. She is passionate about executing clinical trials with agile and innovative teams and enjoys working with emerging biotech companies to establish flexible, best practice processes.
Lily Cappalletti
Ankita Deshpande